Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Walking Speed and Health-Related Quality of Life in Multiple Sclerosis.
Cognition in MS correlates with resting-state oscillatory brain activity: An explorative MEG source-space study.
Disclosure of diagnosis of multiple sclerosis in the workplace positively affects employment status and job tenure.
Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.
D313Y mutation in the differential diagnosis of white matter lesions: Experiences from a multiple sclerosis outpatient clinic.
Long-term assessment of No Evidence of Disease Activity with natalizumab in relapsing multiple sclerosis.
An observational study of venoplasty in patients with multiple sclerosis.
Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing- remitting multiple sclerosis.
Association between smoking and cognitive impairment in multiple sclerosis.
The antibody genetics of multiple sclerosis: comparing next-generation sequencing to sanger sequencing.
A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis.
Traumatic fatal cerebral hemorrhage in an old patient with a history of multiple sclerosis under dabigatran: a case report and review of the literature.
The Anti-Aging Protein Klotho Enhances Remyelination Following Cuprizone-Induced Demyelination.
[Neuropathology of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy].
Comparison between balanced steady-state free precession and standard spoiled gradient echo magnetization transfer ratio imaging in multiple sclerosis: methodical and clinical considerations.
Asynchrony in Executive Networks Predicts Cognitive Slowing in Multiple Sclerosis.
Familial clustering in Italian progressive-onset and bout-onset multiple sclerosis.
Increasing consistency of disease biomarker prediction across datasets.
I-BET151 selectively regulates IL-6 production.
Evaluation of the Innermost Retinal Layers and Visual Evoked Potentials in Patients with Multiple Sclerosis.
Immune-regulatory mechanisms of classical and experimental multiple sclerosis drugs: special focus on helminth-derived treatments.
Quality of life and coping strategies in Lebanese Multiple Sclerosis patients: A pilot study.
Decreased regenerative capacity of oligodendrocyte progenitor cells (NG2-glia) in the ageing brain: a vicious cycle of synaptic dysfunction, myelin loss and neuronal disruption?
The P66Shc/Mitochondrial Permeability Transition Pore Pathway Determines Neurodegeneration.
What do multiple sclerosis patients and their caregivers perceive as unmet needs?
Pages
« first
‹ previous
…
519
520
521
522
523
524
525
526
527
…
next ›
last »